FDA Inspection 1233914 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on March 22, 2024 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 22, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 61 | 21 CFR 606.60(a) | Provide proper equipment to meet requirements |